Feldman, Eva L.
Callaghan, Brian C.
Pop-Busui, Rodica
Zochodne, Douglas W.
Wright, Douglas E.
Bennett, David L.
Bril, Vera
Russell, James W.
Viswanathan, Vijay
Article History
Accepted: 2 May 2019
First Online: 13 June 2019
Competing interests
: B.C.C. consults for a Patient-Centered Outcomes Research Institute (PCORI) grant, the Immune Tolerance Network and DynaMed and performs medical legal consultations. D.L.B. has undertaken consultancy work on behalf of Oxford Innovation for Abide, Biogen, GSK, Lilly, Mitsubishi Tanabe, Mundipharma, Teva and Theranexus. All other authors declare no competing interests.
Free to read: This content has been made available to all.